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1. Introduction
   Venomous snakebite is a WHO identified common acute 
medical emergency in most rural areas of the tropical and 
subtropical countries like India. Approximately 35 000–50 000 
deaths are reported due to snakebite each year[1]. India has 
rich assortment of snake fauna, of which 242 species have 
been identified including 57 poisonous or harmful species. 
The four major ubiquitous species of venomous snakes 
in India, known as “big four” are considered responsible 
for life-threatening envenomation around the country. 
They include Indian cobra (Naja naja), the common krait 
(Bungarus caeruleus), the Russell’s viper (Daboia russelii) 
and the saw-scaled viper (Echis carinatus[2]. Many plants 
viz. Mimosa pudica[3], Mucuna pruriens[4,5], Andrographis 
paniculata and Aristolochia indica[6-8], Acalypha indica[9-
12] are reported to inhibit krait and cobra venom activity. 
Cordia macleodii (Ehretiacae), known as Dahiman in Hindi 
is a rare medicinal and timber plant found in moist, dry 
deciduous forests and successfully used for the treatment 
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Objective: To evaluate the antivenom potential of ethanolic extract of bark of Cordia macleodii 
against Naja venom induced pharmacological effects such as lethality, hemorrhagic lesion, 
necrotizing lesion, edema, cardiotoxicity and neurotoxicity.
Methods: Wistar strain rats were challenged with Naja venom and treated with the ethanolic 
extract of Cordia macleodii bark. The effectiveness of the extract to neutralize the lethalities of 
Naja venom was investigated as recommended by WHO. 
Results: At the dose of 400 and 800 mg/kg ethanolic extract of Cordia macleodii bark significantly 
inhibited the Naja venom induced lethality, hemorrhagic lesion, necrotizing lesion and edema 
in rats. Ethanolic extract of Cordia macleodii bark was effective in neutralizing the coagulant 
and defibrinogenating activity of Naja venom. The cardiotoxic effects in isolated frog heart and 
neurotoxic activity studies on frog rectus abdominus muscle were also antagonized by ethanolic 
extract of Cordia macleodii bark.
Conclusions: It is concluded that the protective effect of extract of Cordia macleodii against 
Naja venom poisoning may be mediated by the cardiotonic, proteolysin neutralization, anti-
inflammatory, antiserotonic and antihistaminic activity. It is possible that the protective effect 
may also be due to precipitation of active venom constituents. 
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of snakebites by traditional healers in Chhattisgarh State 
of India. The leaves of the plant has been reported to have 
anti-inflammatory activity[13]. The present study was aimed 
to examine the snake venom neutralization potential of 
ethanolic extract of Cordia macleodii bark to scientifically 
validate the traditional claim.
 
2. Materials and methods
2.1. Plant material and preparation of extract
   The bark of Cordia macleodii was collected during the 
month of December 2009 from Marwahi Forest Division, 
Pendra Road, Bilaspur (Voucher number: SLT/Med. 
Plant/2009/15). The plant material was taxonomically 
identified and authenticated by Dr. Manoj Singh, Assistant 
Professor, Tulsi Mahavidyalaya, Anuppur (M.P). The shade 
dried coarsely powdered plant material (1.5 kg) was extracted 
with 70% ethanol in a Soxhlet apparatus. The extract was 
dried under vacuum (yield 8.7%). Preliminary phytochemical 
screening was carried out to detect the presence of steroids, 
carbohydrates, flavonoids, alkaloids, etc.
2.2. Experimental animals
   Healthy adult male Wistar albino rats weighing about 180-
250 g and Swiss albino mice weighing about 20-25 g between 
2 and 3 months of age were used for the study. Animals were 
housed individually in polypropylene cages, maintained under 
standard conditions [12 h light and 12 h dark cycle; (25依3) °C]. 
The animals were fed with standard rat pellet diet (Pranav 
Agro Industries Ltd, Baroda, India) and water ad libitum. The 
study was approved by Institutional Animal Ethics Committee 
of the institute (Registration no. 994/ac/06/CPCSEA).
2.3. Venom
   The Naja (Naja naja) venom was obtained from Kanan 
Pendari Zoo, Bilaspur, Chhattisgarh, India and was preserved 
at 4 °C. Before use, the venom was dissolved in saline, 
centrifuged at 2 000 r/min for 10 min and the supernatant 
was used for antivenom studies. Venom concentration was 
expressed in term of dry weight.
2.4. Snake venom antiserum
   Liquid snake antivenin (polyvalent) IP, Biological E. Ltd., 
Hyderabad (Batch no.: 90, Mfg Date: March 2009) was obtained 
from Primary Health Center, Pendra Road, Bilaspur.
2.5. Acute toxicity studies
   The acute toxicity study was carried out as per OECD 423 
guidelines. The limit test for acute toxicity was carried out at 
2 g/kg oral dose. Nulliparous and non-pregnant female rats 
were used for the study and were observed continuously for 
24 h for behavioral, neurological and autonomic profiles and, 
after a period of 24 and 72 h, for any lethality, morbidity state 
or death[14].
2.6. Neutralization of lethal venom effect
   The toxicity of Naja venom was assessed by i.p. 
administration of different concentrations of venom 
dissolved in 0.2 mL of physiological saline to groups (n=6) 
of Wistar albino rats (180–250 g). The median lethal dose 
(LD50) of venom was determined 24 h later by the method 
of Theakston and Reid 1983[15]. The antivenom potential 
of ethanolic extract of bark of Cordia macleodii (CME) was 
assessed by i.p. administration of LD50 dose of venom into 
groups of rats (n=6), followed by i.p. administration of 
different doses of the plant extract. The standard reference 
group was administered snake venom antiserum after 
administration of LD50 dose of venom. 
2.7. Neutralization of hemorrhagic activity
   The minimum haemorrhagic dose is defined as the least 
amount of venom which when injected intradermally into 
rats results in a haemorrhagic lesion of 10 mm diameter 
in 24 h[15]. Neutralization of the haemorrhagic activity was 
estimated by mixing a fixed amount of venom with different 
amounts of CME. The CME–venom mixture was incubated 
at 37 °C for 1 h and 0.1 mL of the mixture was injected 
intradermally into mice. The haemorrhagic lesion was 
estimated after 24 h[4].
2.8. Neutralization of necrotizing activity
   The minimum necrotizing dose is the least amount of 
venom which when injected intradermally into rats results 
in a necrotizing lesion of 5 mm diameter in 3 d later[15]. 
Neutralization of the necrotizing activity was estimated by 
mixing a fixed amount of venom with different amounts of 
CME. The CME–venom mixture was incubated at 37 °C for 1 
h and 0.1 mL of the mixture was injected intradermally into 
mice. The necrotizing lesion was estimated after 3 d. 
2.9. Neutralization of coagulant activity
   The neutralization of coagulant activity was estimated 
by mixing different amount of CME, with a fixed amount 
of venom, incubating for 30 min at 37 °C[4]. Different 
concentration of incubate were added to the experimental 
tube in place of 0.1 mL physiological saline, and the clotting 
time was recorded. 
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2.10. Minimum defibrinogenating dose (MDD) 
   The MDD of venom is defined as the minimum amount of 
venom injected i.v. into mice, causes incoagulable blood 1 h 
later[15]. Neutralization of this activity was estimated as the 
amount of CME which prevented defibrinogenation by the 
MDD. Various amounts of CME were mixed with the MDD of 
the venom, incubated for 30 min at 37 °C and then injected 
i.v. into six mice (20-25 g) . After 1 h mice were anesthetized 
with ether and bled by cardiac puncture. The coagulation 
was observed as described above. The neutralization ability 
of CME was expressed as the effective dose (ED), defined 
as the lowest CME/venom ratio in which blood coagulation 
occurred in the six mice.
2.11. Rat paw edema
   The minimum edematic dose of venom/carrageenan is 
defined as the least amount of venom/carrageenan injected 
by intraplanter route to rats, produce inflammation in 
paw[16]. Non fasted male albino rats (150-200 g) were treated 
with different doses of venom, carrageenan and CME. Venom 
(1 µg/kg)/carrageenan (1% in 0.01 mL) were injected in right 
hind paw after 15 min. As a control, equal amount of saline 
were injected in hind paw.The CME was administered orally. 
The edematic response was evaluated by the use of a screw 
gauge at given time intervals.
2.12. Neutralization of cardiotoxic activity
   The effect of the CME on Naja venom induced changes 
in isolated frog heart was determined by the method of 
Kannappa et al[17]. The isolated frog heart was connected to 
the perfusion apparatus containing Ringer solution, graded 
doses of the CME and Naja venom were injected and the 
changes in heart rate were recorded using kymograph (speed 
12 mm/h, INCO instruments, Ambala, India). The effects of 
Naja venom in the presence of CME were also studied. The 
experiment was repeated in six isolated preparations[9]. 
2.13. Neutralization of neurotoxic activity 
   The effect of CME on Naja venom induced changes on 
skeletal muscle was determined by the method reported 
by Kannappa et al[17]. The rectus abdominus muscle of frog 
was mounted in an organ bath containing Ringer solution. 
The effect of acetylcholine, CME and Naja venom per se and 
the effect of acetylcholine and Naja venom in the presence 




   Results are expressed as mean依SEM. The data were 
analyzed by ANOVA complemented by the Tukey–Kramer 
test. Values of P<0.05 were considered significant.
 
3. Results
   The LD50 of Naja venom was established at 120 µg/rat 
i.p.. The MHD was 240 µg/rat and the MND at 150 µg/rat 
respectively. Oral administration of the CME did not produce 
toxic effects up to 2 g/kg in rats after 72 h.
   The data from in vivo studies indicate protection by 
CME against the Naja venom induced lethality in a dose-
dependent manner. Significant protection was observed at 
200 and 400 mg/kg. At the dose of 800 mg/kg CME showed 
higher protection than snake venom antiserum (Table 1). The 
rate of survived animals was increased to 100%. 
Table 1 
Effect of the CME on the lethality of Naja venom.
Group (n=6) % Survival % Increase in survival rate
Control (Snake Venom) 50.00 -
Standard (Snake Antivenin)  83.30a  66.60
CME (200 mg/kg)  66.00b  32.00
CME (400 mg/kg)  83.30a  66.60
CME (800 mg/kg) 100.00a 100.00
aP<0.01 vs. Control, bP<0.05 vs. Control 
   The MND of venom injected intradermally into rat’s shaved 
dorsal skin caused necrotizing and hemorrhagic lesions. 
The CME at 200 mg/kg reduced the necrotizing as well as 
hemorrhagic lesions significantly (Table 2). Blood treated 
with venom clotted faster than untreated blood. About 61.11 
µg of Naja venom clotted human citrated plasma within 
60 seconds. In the neutralization assay, the absence of clot 
formation shows the neutralizing ability of the CME. The CME 
at (1.81依0.11) mg of dose was able to completely neutralize 
coagulant activity (Table 3). The Naja venom also induced 
defibrination in vivo and this activity was neutralized 
successfully by CME at (2.10依0.21) mg dose (Table 4). 
Table 2 
Effect of the CME on hemorrhagic and necrotizing lesion.
Group (n=6) Hemorrhagic  lesion 
(mm) 
Necrotizing  lesion 
(mm)  
Control (Snake venom) 10.26依0.20 5.12依0.28
Standard (Snake antivenin) 0.00a 0.00 a
CME (200 mg/kg) 6.18依0.08b 3.16依0.21b
CME (400 mg/kg) 4.78依0.20a 2.92依0.15a
CME (800 mg/kg) 3.25依0.21a 2.75依0.11a
aP<0.01 vs. Control, bP<0.05 vs. Control 
Table 3  
Neutralization of coagulant activity.
Venom MCD (µg/mL)a  Effective dose of neutralizationb(mg CME/mg venom) 
Naja 61.11依0.21 1.81依0.11
a
Defined as the concentration of venom (µg /ml) which induced 
coagulation of plasma in 60 seconds (mean依SEM; n=6). 
b
Defined as the CME/venom ratio at which coagulation time was 
increased three times when compared to coagulation time of plasma 
incubated with venom alone (mean依SEM; n=6).  
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Table 4 
Neutralization of defibrinogenating activity.




Defined as the minimum amount of venom which, when injected i.v. 
into mice, causes incoagulable blood 1 h later. Six mice were used per 
experimental group. bNeutralization ability of CME was expressed as 
effective dose, defined as the lowest CME /venom ratio in which blood 
coagulation occurred in the six mice.
   Carrageenan and Naja venom induced significant edema 
in rat paw. Maximum inflammation was seen at 1 h which 
gradually decreased over a period of time. Intraplantar 
Naja venom injection followed by CME produced significant 
reduction in inflammation at 400 mg/kg dose (Table 5). The 
venom produced cardiotoxic effect and reduced the heart 
rate. The venom mixed with different amount of CME did not 
produce cardiotoxic effects. The effect was significant as 
compared to constant dose V3 of the venom. The protective 
action was increased with the increase in dose indicating 
the dose dependent protection (Table 6 and Figure 1).
Table 5 
Carrageenan and Naja venom induced edema and its inhibition by CME.
Treatment
Edema (mL)
1h 2h 3h 4h
Carrageenan 7.25依0.21 6.84依0.24 6.75依0.21 5.67依0.21
Naja venom 9.48依0.11   9.25依0.11 8.75依0.21 8.50依0.25
Snake antivenin  4.58依0.32a  4.67依0.27a  5.05依0.30b  5.30依0.20b
CME (400 mg/kg)  7.08依0.20b 8.25依0.11 8.25依0.11 8.25依0.21
CME (800 mg/kg)  5.08依0.15a  5.75依0.30b 7.25依0.17 7.50依0.12
aP<0.01 vs. Naja venom, bP<0.05 vs. Naja venom
Table 6 
Effect of CME on isolated frog heart.
Dose Heart rate/min
Normal Saline (N) 56.33依0.42
C1 (100 µg) 44.33依0.33
C2 (200 µg) 40.83依0.30
C3 (400 µg) 40.83依0.70
C4 (800 µg) 40.50依0.42
C5 (1600 µg) 42.60依0.84
V1 (1 µg) 34.32依0.51
V2 (2 µg) 28.22依0.49
V3 (4 µg) 21.13依0.42
V3 + C1 24.11依0.21
V3 + C2 26.41依0.32
V3 + C3 34.50依0.50
b
V3 + C4 40.66依0.42
b
V3 + C5 48.50依0.76
a
aP<0.01 vs. V3, bP<0.05 vs. V3, C1 to C5 -Different doses of CME, V1 to 
V3: Different doses of Naja venom.
Cardiac arrest
   N    C1      C2       C3    C4   C5   V1  V2  V3 V3+C1 V3+C2 V3+C3 V3+C4  V3+C5
Figure 1. Effect of ethanolic bark extract of Cordia macleodii on isolated frog 
heart in the presence of Naja venom.
   In neurotoxic activity studies on frog rectus abdominus 
muscle, the addition of Naja venom (6 µg/mL) to the bath 
produced inhibition of the muscle to the stimulant effect of 
acetylcholine. This effect was significantly inhibited by the 
CME at the dose of 400 µg/mL. 
 
4. Discussion
   Snake bite remains a public health problem in many 
countries even though it is difficult to be precise about the 
actual number of cases[18]. Medicinal plants have been used 
for many years to treat a great variety of diseases including 
envenomations by animal bites. Therefore, experimental 
validation of the traditional use of plants is a necessary 
step in the development of low-cost phytotherapeutic 
agents. Many plants are recommended in Indian traditional 
medicine to treat snakebites some of which have been 
examined for neutralization of snake venom. The present 
investigation identified bark of Cordia macleodii, reported 
in Ayurvedic literature to have significant antivenom 
activity against Naja venom[6]. Administration of the 
alcoholic extract of Cordia macleodii bark at 200, 400 and 
800 mg/kg body weight markedly reduced the mortality in 
rats. The Naja venom induced lethality was antagonized 
by CME in a dose dependent manner. Highly significant 
protection was observed at the dose of 800 mg/kg which was 
even more than the snake venom antiserum. 
   According to the WHO, the anti snake venom compounds 
should be tested regarding its capacity to neutralize venom 
effects such as lethality, hemorrhagic-necrotizing effects, 
neutralization of the coagulant and defibrinogenating 
activity[15]. Most venom possesses the ability to cause local 
necrosis and hemorrhage when introduced intradermally. 
Hence, the minimum necrotizing dose and minimum 
hemorrhagic dose estimation proves a reasonable test 
for assessing the antivenom activity[9]. Hemorrhagins of 
venom causes death because of bleeding from vital organs 
by damaging vascular endothelium[19]. The Naja venom 
contains most of the components which are responsible for 
the destruction of physiological process in the body. Several 
components are present in Naja venom like enzymes, 
proteolysins, cardiotoxins, hemorrhagins, cytolysins and 
neurotoxins. The CME was found to significantly reduce the 
Naja venom induced necrotic and hemorrhagic lesions. 
In both the studies the CME showed highly significant 
resultsindicating the protective effect of CME against Naja 
venom induced lethality.
   As a consequence of Naja bite local necrosis occur, which 
is often due to clot formation[20]. In patients who suffer 
from snake bites marked progress of defibrination has been 
observed[21]. CME effectively antagonized the clotting and 
defibrination induced by Naja venom indicating that CME 
possess protective effect against Naja venom poisoning.
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   The Naja venom containing one of the harmful 
components, proteolysin, is responsible for the local pain 
and swelling. In our study Naja venom induced the edema 
in rat paw indicating the edematogenic activity of the 
venom. The CME decreased the edema induced by venom 
indicating the antiedematogenic activity of CME. The Cordia 
macleodii  has been reported to have antiinflammatory 
activity[10]. The hesperetin-7-rhamnoside Lupa-20, 
isolated from Cordia species possess anti inflammatory 
and proteolysin neutralization activity[22]. The CME might 
be showing antiedematogenic activity due to its anti 
inflammatory and proteolysin neutralization activity. 
   Naja venom contains large amount of cardiotoxin and 
phosphodiesterases. It is harmful for body, decreases 
heart rate and may cause cardiac arrest. In our study, an 
attempt was made to determine the possible involvement 
of the cardiac system in the protective effect against 
Naja venom. The CME was found to prevent the cardiac 
arrest produced by venom in dose dependent manner. 
The Cordia bark has been reported to have cardiotonic 
activity and the aqueous extract was reported to produce 
significant positive inotropic and chronotropic effects on 
rat`s heart[23]. Cordia species has been reported to have 
cardiac glycoside, cordialin a, cordialin B. The preliminary 
phytochemical studies on CME indicated the presence of 
cardiac glycosides[24]. The presence of cardiac glycosides 
might be responsible for the prevention of cardiac arrest 
and decrease in the heart rate.
   Venom releases an enormous amount of histamine 
into circulation by mast cell degranulation. The released 
substances could also add to the various toxic signs and 
in fact may be responsible for some of the toxicity such 
as anaphylaxis. Mast cells are a rich source of mediators 
like histamine and platelet activating factors[25]. The 
preliminary phytochemical analysis indicated the presence 
of flavonoids in CME. The flavonoids are reported to have 
anti-inflammatory, antihistaminic, antibradykinin and 
antiserotonin properties. The presence of flavonoids 
might be responsible for the protective effect shown by 
the CME against snake venom poisoning though it’s anti-
inflammatory, antihistaminic and antiserotonic activity[26].
   The Cordia macleodii bark is being successfully used 
for the treatment of snakebites in Chhattisgarh State. 
Extensive phytochemical studies carried out on this plant 
and wide class of compounds including flavonol glycosides, 
pyrollizidine alkaloids, triterpenes, cardiaquinones, 
sphingolipids, cerebrosides were isolated[19]. Hence it 
may be postulated that the anti-snake venom activity of 
CME might be mediated by the cardiotonic, proteolysin 
neutralization, anti-inflammatory, antiserotonic and 
antihistaminic activity. It is possible that the protective 
effect against snake venom may also be due to precipitation 
of active venom constituents.
   However more elaborate work is required to establish the 
efficacy of CME as potent anti-snake venom drug. Further 
experimental work is being carried out to isolate and 
identify the active principles present in the CME that are 
responsible for anti-snake venom activity.
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Comments 
Background
   Most of the snakebites recorded in India are caused by 
the 
Naja  na ja .  Numerous  s tud ies  a re  focus ing   on 
supplementary alternatives, such as the use of medicinal 
plants. Cordia  macleodii has already demonstrated 
anti-inflammatory and  healing properties. The present 
researchwork represents antivenom potential of ethanolic 
extract of Cordia macleodii bark against Naja venom.
  
Research frontiers
   In  the current study,  the bark of Cordia macleodii 
neutralized the toxic activities of Naja naja snake venom 
and the activity was evaluated by using various parameters 
laid down by WHO. 
Related reports
   Snake venoms are a complex mixture of toxic enzymes and 
proteins such as phospholipases A, myotoxins, hemorrhagic 
metalloproteases, clotting serineproteases, neurotoxins, 
cytotoxins and others. Snakebite envenomations are 
frequently treated with parenteral administration  of  horse- 
or  sheep-derived  antivenoms aiming at the neutralization 
of toxins. Large number of plants have been reported to 
neutralize the snake vemon toxicities. 
Innovations and breakthroughs
   Cordia macleodii is a well known medicinal plant used for 
the  treatment of snakebite and cardiac tonic by traditional 
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healers. But no scientific data is reported for its use against 
snake  bite. In present study, authors have scientifically 
tried to investigate the antivenom properties of Cordia 
macleodii extract against snake venom.
  
Applications
  Despite the success of serum therapy, it is important to 
search for different venom inhibitors, either synthetic or 
natural, which would complement the action of antivenoms, 
particularly in relation to the neutralization of local tissue 
damage. Plant extracts constitute an extremely rich source 
of pharmacologically active compounds, and a number of 
extracts has been shown to act against snake venom.   
Peer review
   This is a valuable research work in which authors have 
demonstrated the antivenom potential of ethanolic extract 
of Cordia macleodii bark against Naja venom. Cordia 
macleodii can be promising antidote against Naja venom 
poisoning.   
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